Akari Therapeutics Plc - 8-K Filing

Akari Therapeutics shareholders approve increase in share pool for the 2023 Plan at Special General Meeting. (Items: 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $AKTX

Read the full article at SEC EDGAR

More Regulatory news